117 related articles for article (PubMed ID: 15263791)
1. E-cadherin expression in prostate adenocarcinomas in Chinese and its pathological correlates.
Hsu YS; Wang JS; Wu TT
Urol Int; 2004; 73(1):36-40. PubMed ID: 15263791
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens.
De Marzo AM; Knudsen B; Chan-Tack K; Epstein JI
Urology; 1999 Apr; 53(4):707-13. PubMed ID: 10197845
[TBL] [Abstract][Full Text] [Related]
3. Expression of E-cadherin in prostate cancer in formalin-fixed, paraffin-embedded tissues: correlation with pathological features.
Köksal IT; Ozcan F; Kiliçaslan I; Tefekli A
Pathology; 2002 Jun; 34(3):233-8. PubMed ID: 12109783
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.
Rubin MA; Mucci NR; Figurski J; Fecko A; Pienta KJ; Day ML
Hum Pathol; 2001 Jul; 32(7):690-7. PubMed ID: 11486167
[TBL] [Abstract][Full Text] [Related]
5. The role of p53, bcl-2 and E-cadherin expression in predicting biochemical relapse for organ confined prostate cancer in Taiwan.
Wu TT; Hsu YS; Wang JS; Lee YH; Huang JK
J Urol; 2003 Jul; 170(1):78-81. PubMed ID: 12796649
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-Mesenchymal Transition Markers β-catenin, Snail, and E-Cadherin do not Predict Disease Free Survival in Prostate Adenocarcinoma: a Prospective Study.
Ipekci T; Ozden F; Unal B; Saygin C; Uzunaslan D; Ates E
Pathol Oncol Res; 2015 Sep; 21(4):1209-16. PubMed ID: 26037169
[TBL] [Abstract][Full Text] [Related]
7. Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors.
Nariculam J; Freeman A; Bott S; Munson P; Cable N; Brookman-Amissah N; Williamson M; Kirby RS; Masters J; Feneley M
Asian J Androl; 2009 Jan; 11(1):109-18. PubMed ID: 19050681
[TBL] [Abstract][Full Text] [Related]
8. [Expressions of E-cadherin and N-cadherin in prostate cancer and their implications].
Liu Y; Chen XG; Liang CZ
Zhonghua Nan Ke Xue; 2014 Sep; 20(9):781-6. PubMed ID: 25306803
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic Study of Gleason Pattern 5 Prostatic Adenocarcinoma With "Single-cell" Growth Reveals 2 Distinct Types, One With "Plasmacytoid" Features.
Nguyen JK; Chen YY; Magi-Galluzzi C; McKenney JK
Am J Surg Pathol; 2020 Dec; 44(12):1635-1642. PubMed ID: 32991340
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of some tissue and serum biomarkers in prostatic carcinoma among Egyptian males.
Ahmed MI; Abd-Elmotelib F; Farag RM; Ziada NA; Khalifa A
Clin Biochem; 1999 Aug; 32(6):439-45. PubMed ID: 10667479
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and p120ctn in prostate cancer specific survival: a long-term follow-up study.
van Oort IM; Tomita K; van Bokhoven A; Bussemakers MJ; Kiemeney LA; Karthaus HF; Witjes JA; Schalken JA
Prostate; 2007 Sep; 67(13):1432-8. PubMed ID: 17639504
[TBL] [Abstract][Full Text] [Related]
12. Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers.
Kuniyasu H; Troncoso P; Johnston D; Bucana CD; Tahara E; Fidler IJ; Pettaway CA
Clin Cancer Res; 2000 Jun; 6(6):2295-308. PubMed ID: 10873080
[TBL] [Abstract][Full Text] [Related]
13. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
[TBL] [Abstract][Full Text] [Related]
14. N-cadherin switching occurs in high Gleason grade prostate cancer.
Jaggi M; Nazemi T; Abrahams NA; Baker JJ; Galich A; Smith LM; Balaji KC
Prostate; 2006 Feb; 66(2):193-9. PubMed ID: 16173043
[TBL] [Abstract][Full Text] [Related]
15. Expression of α5-integrin, α7-integrin, Ε-cadherin, and N-cadherin in localized prostate cancer.
Drivalos A; Chrisofos M; Efstathiou E; Kapranou A; Kollaitis G; Koutlis G; Antoniou N; Karanastasis D; Dimopoulos MA; Bamias A
Urol Oncol; 2016 Apr; 34(4):165.e11-8. PubMed ID: 26652134
[TBL] [Abstract][Full Text] [Related]
16. The relative mRNA expression levels of matrix metalloproteinase to E-cadherin in prostate biopsy specimens distinguishes organ-confined from advanced prostate cancer at radical prostatectomy.
Kuniyasu H; Ukai R; Johnston D; Troncoso P; Fidler IJ; Pettaway CA
Clin Cancer Res; 2003 Jun; 9(6):2185-94. PubMed ID: 12796385
[TBL] [Abstract][Full Text] [Related]
17. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.
Hattab EM; Koch MO; Eble JN; Lin H; Cheng L
J Urol; 2006 May; 175(5):1695-9; discussion 1699. PubMed ID: 16600733
[TBL] [Abstract][Full Text] [Related]
18. Expression of E-cadherin in primary prostate cancer: correlation with clinical features.
Kuczyk M; Serth J; Machtens S; Bokemeyer C; Bathke W; Stief C; Jonas U
Br J Urol; 1998 Mar; 81(3):406-12. PubMed ID: 9523661
[TBL] [Abstract][Full Text] [Related]
19. Evidence of surfactant protein A and D expression decrement and their localizations in human prostate adenocarcinomas.
Kankavi O; Baykara M; Eren Karanis MI; Bassorgun CI; Ergin H; Ciftcioglu MA
Ren Fail; 2014 Mar; 36(2):258-65. PubMed ID: 24168624
[TBL] [Abstract][Full Text] [Related]
20. Co-downregulation of cell adhesion proteins alpha- and beta-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas.
Kallakury BV; Sheehan CE; Ross JS
Hum Pathol; 2001 Aug; 32(8):849-55. PubMed ID: 11521230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
